PMC:7306567 / 9601-9745
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 89 | 124-135 | Chemical | denotes | oseltamivir | MESH:D053139 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T41 | 67-82 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
| T42 | 90-114 | Chemical | denotes | neuraminidase inhibitors | http://purl.obolibrary.org/obo/CHEBI_52425 |
| T43 | 104-114 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T44 | 124-135 | Chemical | denotes | oseltamivir | http://purl.obolibrary.org/obo/CHEBI_7798 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T62 | 0-144 | Sentence | denotes | Other factors that have been implicated in IAPA include the use of corticosteroids and of neuraminidase inhibitors, such as oseltamivir [7, 30]. |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T67 | 67-82 | CHEBI:50858;CHEBI:50858 | denotes | corticosteroids |
| T68 | 104-114 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
| T69 | 124-135 | CHEBI:7798;CHEBI:7798 | denotes | oseltamivir |
| T78005 | 67-82 | CHEBI:50858;CHEBI:50858 | denotes | corticosteroids |
| T22610 | 104-114 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
| T97282 | 124-135 | CHEBI:7798;CHEBI:7798 | denotes | oseltamivir |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32572532-22895826-47963418 | 137-138 | 22895826 | denotes | 7 |
| T47034 | 137-138 | 22895826 | denotes | 7 |